Shandong Lukang Pharmaceutical Co Ltd (600789) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.002x

Based on the latest financial reports, Shandong Lukang Pharmaceutical Co Ltd (600789) has a cash flow conversion efficiency ratio of -0.002x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-6.39 Million ≈ $-935.75K USD) by net assets (CN¥4.10 Billion ≈ $600.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. View Shandong Lukang Pharmaceutical Co Ltd (600789) share price today for real-time trading data and today's change.

Shandong Lukang Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Shandong Lukang Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see Shandong Lukang Pharmaceutical Co Ltd market cap and net worth for the company's overall valuation and market capitalisation.

Shandong Lukang Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shandong Lukang Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see 600789 total assets for a full breakdown of the balance sheet.

Company	Cash Flow Conversion Efficiency
Aktis Oncology, Inc. Common stock NASDAQ:AKTS	0.097x
Zhejiang Tianyu Pharmaceutical Co Ltd SHE:300702	0.063x
Carlsberg Brewery Malaysia Bhd KLSE:2836	0.636x
Hagar hf IC:HAGA	0.078x
VIEL & Cie société anonyme PA:VIL	0.111x
Shanghai Electric Group Company Limited F:USR	0.061x
Guangdong South New Media Co Ltd SHE:300770	-0.010x
Universal Corporation NYSE:UVV	-0.082x

Annual Cash Flow Conversion Efficiency for Shandong Lukang Pharmaceutical Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Shandong Lukang Pharmaceutical Co Ltd from 1998 to 2025. Review Shandong Lukang Pharmaceutical Co Ltd (600789) financial flexibility to assess the company's free cash flow relative to its total liabilities.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥5.26 Billion ≈ $769.21 Million	CN¥698.17 Million ≈ $102.16 Million	0.133x	+33.92%
2024-12-31	CN¥4.06 Billion ≈ $594.34 Million	CN¥402.82 Million ≈ $58.94 Million	0.099x	-38.57%
2023-12-31	CN¥3.74 Billion ≈ $547.48 Million	CN¥604.01 Million ≈ $88.39 Million	0.161x	+27.41%
2022-12-31	CN¥3.51 Billion ≈ $513.21 Million	CN¥444.38 Million ≈ $65.03 Million	0.127x	+188.43%
2021-12-31	CN¥3.40 Billion ≈ $497.41 Million	CN¥149.33 Million ≈ $21.85 Million	0.044x	-37.08%
2020-12-31	CN¥3.36 Billion ≈ $491.57 Million	CN¥234.55 Million ≈ $34.32 Million	0.070x	-38.80%
2019-12-31	CN¥3.17 Billion ≈ $464.11 Million	CN¥361.87 Million ≈ $52.95 Million	0.114x	-0.18%
2018-12-31	CN¥3.07 Billion ≈ $449.48 Million	CN¥351.09 Million ≈ $51.37 Million	0.114x	-12.93%
2017-12-31	CN¥2.10 Billion ≈ $307.12 Million	CN¥275.51 Million ≈ $40.32 Million	0.131x	-12.17%
2016-12-31	CN¥1.98 Billion ≈ $290.03 Million	CN¥296.23 Million ≈ $43.35 Million	0.149x	+263.29%
2015-12-31	CN¥1.91 Billion ≈ $278.80 Million	CN¥78.39 Million ≈ $11.47 Million	0.041x	-43.00%
2014-12-31	CN¥1.50 Billion ≈ $220.11 Million	CN¥108.56 Million ≈ $15.89 Million	0.072x	-54.00%
2013-12-31	CN¥1.63 Billion ≈ $239.22 Million	CN¥256.50 Million ≈ $37.53 Million	0.157x	+118.86%
2012-12-31	CN¥1.61 Billion ≈ $235.15 Million	CN¥115.20 Million ≈ $16.86 Million	0.072x	-1.52%
2011-12-31	CN¥1.69 Billion ≈ $247.82 Million	CN¥123.28 Million ≈ $18.04 Million	0.073x	-60.49%
2010-12-31	CN¥1.68 Billion ≈ $245.35 Million	CN¥308.88 Million ≈ $45.20 Million	0.184x	+42.96%
2009-12-31	CN¥1.55 Billion ≈ $226.53 Million	CN¥199.49 Million ≈ $29.19 Million	0.129x	-7.63%
2008-12-31	CN¥1.50 Billion ≈ $219.63 Million	CN¥209.39 Million ≈ $30.64 Million	0.140x	+48.39%
2007-12-31	CN¥1.46 Billion ≈ $213.69 Million	CN¥137.30 Million ≈ $20.09 Million	0.094x	+137.70%
2006-12-31	CN¥1.42 Billion ≈ $208.09 Million	CN¥56.24 Million ≈ $8.23 Million	0.040x	-63.33%
2005-12-31	CN¥1.50 Billion ≈ $219.27 Million	CN¥161.64 Million ≈ $23.65 Million	0.108x	+155.06%
2004-12-31	CN¥1.50 Billion ≈ $218.82 Million	CN¥63.24 Million ≈ $9.25 Million	0.042x	-59.21%
2003-12-31	CN¥1.61 Billion ≈ $236.31 Million	CN¥167.42 Million ≈ $24.50 Million	0.104x	-58.61%
2002-12-31	CN¥1.26 Billion ≈ $184.36 Million	CN¥315.59 Million ≈ $46.18 Million	0.250x	+7.61%
2001-12-31	CN¥1.16 Billion ≈ $170.00 Million	CN¥270.43 Million ≈ $39.57 Million	0.233x	+1077.05%
2000-12-31	CN¥1.13 Billion ≈ $165.42 Million	CN¥22.36 Million ≈ $3.27 Million	0.020x	-38.07%
1999-12-31	CN¥1.10 Billion ≈ $160.95 Million	CN¥35.12 Million ≈ $5.14 Million	0.032x	-22.53%
1998-12-31	CN¥1.12 Billion ≈ $163.93 Million	CN¥46.18 Million ≈ $6.76 Million	0.041x	--

About Shandong Lukang Pharmaceutical Co Ltd

SHG:600789 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.12 Billion

CN¥7.66 Billion CNY

Market Cap Rank

#8445 Global

#1965 in China

Share Price

CN¥7.33

Change (1 day)

-4.68%

52-Week Range

CN¥6.76 - CN¥10.71

All Time High

CN¥16.22